These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 932428)

  • 21. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response].
    Spasokukotskiĭ AL
    Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cyclophosphamide on syngeneic transplantation of adenovirus 12-transformed tumor cells in C3H/he mice.
    Pauluzzi S; Merletti L
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):310-5. PubMed ID: 20903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of tolerance induction of tumor-specific delayed-type hypersensitivity responses by intravenous inoculation of tumor cells.
    Sato S; Fukuzawa M; Nakajima H; Ogata M; Kosugi A; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1985 Nov; 76(11):1099-106. PubMed ID: 2935516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation.
    Seeley BM; Barthel SW; To WC; Kjaergaard J; Shu S; Plautz GE
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):436-41. PubMed ID: 11283503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics of hematopoietic system reactions of newborn and adult mice to the growth of syngeneic hepatoma H-2-73].
    Chertkova AI; Belianchikova NI; Bukhman VM
    Biull Eksp Biol Med; 1982 Jun; 93(6):90-2. PubMed ID: 7115945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro.
    Treves AJ; Cohen IR; Feldman M
    J Natl Cancer Inst; 1975 Mar; 54(3):777-80. PubMed ID: 1123855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.
    Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T
    J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Method of assessing the functional activity of tumor-associated suppressor cells].
    Iudin VM; Semenova-Kobzar' RA; Kushko LIa
    Eksp Onkol; 1984; 6(6):37-41. PubMed ID: 6241144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
    Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
    J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Splenocyte functional activity in mice growing the syngeneic transplantable hepatoma 22a].
    Kiseleva EP; Malygin AM
    Tsitologiia; 1984 Dec; 26(12):1409-15. PubMed ID: 6335612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.
    Yron I; Wood TA; Spiess PJ; Rosenberg SA
    J Immunol; 1980 Jul; 125(1):238-45. PubMed ID: 6966652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
    Ostrand-Rosenberg S; Cohn AL; Sandoz JW
    J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.
    Morecki S; Yacovlev E; Gelfand Y; Vilensky A; Slavin S
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):40-8. PubMed ID: 14752778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
    Palathumpat V; Holm B; Dejbakhsh-Jones S; Strober S
    J Immunol; 1992 May; 148(10):3319-26. PubMed ID: 1578152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tryptophan degradation in transplanted tumor cells undergoing rejection.
    Yoshida R; Park SW; Yasui H; Takikawa O
    J Immunol; 1988 Oct; 141(8):2819-23. PubMed ID: 3262668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma cell infiltrate of the primary tumor as a source of early systemic protection against metastases in mice.
    Vaage J; Pepin KG
    J Natl Cancer Inst; 1983 Jul; 71(1):147-55. PubMed ID: 6345879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological behavior of malignant melanoma cells correlated to their survival in vivo.
    Fidler IJ
    Cancer Res; 1975 Jan; 35(1):218-24. PubMed ID: 1109790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electronic cell volume analysis of growth and rejection of EL-4 ascites tumor cells.
    Zucker RM; Harari J; Finley J; Kambour M
    Am J Vet Res; 1978 Oct; 39(10):1710-2. PubMed ID: 717886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.